RDP in the News
September 5, 2023 | Vandana Singh | Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 1, 2023 | Spencer Kimball | CNBC
Judge Withdraws From Medicare Drug Price Case After Stock Ownership Is Revealed
September 1, 2023 | Jake Johnson | Common Dreams
Watchdog Calls On Judge With Pharma Investments to Recuse From Drug Pricing Case
August 31, 2023 | KPFA | Background Briefing
PODCAST: How Big Pharma With the Help of the Corporate-Friendly Supreme Court Could Kill the Lowering of Drug Prices
August 29, 2023 | Yuval Rosenberg & Michael Rainey | The Fiscal Times
Biden Admin Picks First 10 Drugs Targeted for Price Cuts
August 17, 2023 | Newell Normand | Newell Normand Show
Is there a revolving door between the offices of the DEA and Big Pharma?
July 19, 2023 | Joshua Goodman & Jim Mustian | Associated Press
Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma
January 23, 2023 | Jake Johnson | Common Dreams
'Catastrophic Decision': Progressives Rip Choice of Jeff Zients for Chief of Staff
January 22, 2023 | Eugene Daniels, Adam Cancryn and Eli Stokols | Politico
Jeff Zients To Be Biden’s Next Chief Of Staff
January 22, 2023 | Peter Baker, Katie Rogers and Michael D. Shear | The New York Times
Biden to Tap Jeff Zients as His Next White House Chief of Staff
October 31, 2022 | Ben White & Gavin Bade | Politico
The Democratic left has a problem with Gina Raimondo
August 30, 2022 | Rob Galbraith | LittleSis
Anita Dunn advises Biden while her firm undermines Democratic Party priorities
October 29, 2021 | Igor Derysh | Salon
Pro-Pharma Democrats Kill Bill To Lower Drug Costs — Advocates Ask: “What Did They Get For That?”
October 7, 2021 | Morgan Chalfant | The Hill
Biden And Big Business: It's Complicated
September 30, 2021 | Christopher Condon & Craig Torres | Bloomberg